study of Innate lymphoid cells from TC-1 tumors, 1,3 and 7 days after a cisplatin treatment (or PBS as control) Overall design: study of ILCs from PBS or Cisplatin treated TC-1 tumors
Gastric Cancer (GC) is a highly heterogeneous disease. To identify potential clinically actionable therapeutic targets that may inform individualized treatment strategies, we performed whole-exome seq